Affiliation: New York University School of Medicine
- Diagnostic sensitivity of serum and lumbar CSF bHCG in newly diagnosed CNS germinomaJeffrey Allen
NYU Langone Medical Center, New York, NY 10016, USA
Pediatr Blood Cancer 59:1180-2. 2012..There is less information on the diagnostic sensitivity of bHCG assays in germinoma...
- A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931)Jeffrey Allen
Departments of Pediatrics and Pathology, New York University Medical Center, New York, NY 10016, USA
Int J Radiat Oncol Biol Phys 74:1006-11. 2009....
- Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescueJason R Fangusaro
The Children s Hospital Los Angeles, New York University Medical Center, Memorial Sloan Kettering Cancer Center, and Schneider Children s Hospital, USA
Pediatr Blood Cancer 50:715-7. 2008..Two patients survive at least 32 months with stable disease. This approach provides an alternative for young patients with bstPNET who in prior reports have had a uniformly fatal prognosis...
- Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine gliomaRajni Sethi
Department of Radiation Oncology, New York University Langone Medical Center, 566 First Avenue, New York, NY 10014, USA
J Neurooncol 102:121-7. 2011..All patients should undergo routine craniospinal imaging at diagnosis and follow-up. Central nervous system prophylaxis should be considered in future clinical trials...
- Bevacizumab in recurrent high-grade pediatric gliomasAshwatha Narayana
Department of Radiation Oncology, New York University Langone Medical Center, New York, New York 10016, USA
Neuro Oncol 12:985-90. 2010..However, the radiological response rate, response duration, and survival appeared inferior in pediatric patients. Genetic differences in pediatric gliomas might account for this difference...
- Long-term follow-up of children treated for high-grade gliomas: children's oncology group L991 final study reportStephen Alan Sands
Columbia University College of Physicians and Surgeons, New York, NY, USA
J Clin Oncol 30:943-9. 2012..The Children's Oncology Group (COG) L991 study investigated the neuropsychological, behavioral, and quality of life (QoL) outcomes after treatment on the Children's Cancer Group (CCG) trial for high-grade gliomas (CCG-945)...